# PVAC GOLD Versus Irrigated RF Single Tip Catheter With Contact FORCE Ablation of the Pulmonary Veins for Treatment of Drug Refractory Symptomatic Paroxysmal and Persistent Atrial Fibrillation

> **NCT02463851** · NA · COMPLETED · sponsor: **L.V.A. Boersma** · enrollment: 212 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** PVAC GOLD multielectrode catheter
- **DEVICE:** Contact Force single-tip ablation catheter

## Key facts

- **NCT ID:** NCT02463851
- **Lead sponsor:** L.V.A. Boersma
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2021-04-01
- **Final completion:** 2021-04-01
- **Target enrollment:** 212 (ACTUAL)
- **Last updated:** 2021-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02463851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02463851, "PVAC GOLD Versus Irrigated RF Single Tip Catheter With Contact FORCE Ablation of the Pulmonary Veins for Treatment of Drug Refractory Symptomatic Paroxysmal and Persistent Atrial Fibrillation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02463851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*